The aging of the world's population has led to steady annual increases in the number of patients suffering chronic diseases. With demand for long-term care of chronic diseases on the rise, the point-of-care testing (POCT) market has also experienced a boom. "Compared with other types of medical devices, POCT has experienced exceptional market growth recently," said Julie Wun, TrendForce biotechnology analyst. "The global market scale of POCT devices is projected to increase at a CAGR of 9.7% from 2015 to 2020. TrendForce's latest analysis also estimates that the global POCT market reached U$$17.8 billion in 2016. By 2020, the market scale will come to around US$25.6 billion."